(5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone, 95.0%, 100g

TERT-BUTYL (5-BROMOQUINOLIN-2-YL)CARBAMATE, 95.0%, 250mg

(R)-2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthalene, 97%, 1g

CIS-3-HEXENYL SALICYLATE, 95.0%, 25g

(3R,4S)-1-tert-butyl 3-ethyl 4-(((R)-1-phenylethyl)amino)pyrrolidine-1,3-dicarboxylate hydrochloride, 98%, 100mg

N-(2-Aminoethyl)piperazine>99.0%(GC)(T)25mL

VERBASCOSIDE, 98%, 250mg

E-plan EPL S60x/0.85 objective

(5aR,10bS)-2-(2,4,6-Triisopropylphenyl)-4,5a,6,10b-tetrahydroindeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-2-ium tetrafluoroborate, 50mg

D-Glucuronolactone, 98.0%, 1kg

METHYL 4-NITRO-2-TRIFLUOROMETHYLBENZOATE, 98.0%, 10g

N1-Cyclohexylpropane-1,3-diamine, 95.0%, 1g

N-Succinimidyl 7-Methoxycoumarin-3-carboxylate>98.0%(HPLC)(N)1g